The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Diabetic nephropathy—emerging epigenetic mechanisms
Open accessAbstract
Diabetic nephropathy (DN), a severe microvascular complication frequently associated with both type 1 and type 2 diabetes mellitus, is a leading cause of renal failure. The condition can also lead to accelerated cardiovascular disease and macrovascular complications. Currently available therapies have not been fully efficacious in the treatment of DN, suggesting that further understanding of the molecular mechanisms underlying the pathogenesis of DN is necessary for the improved management of this disease. Although key signal transduction and gene regulation mechanisms have been identified, especially those related to the effects of hyperglycaemia, transforming growth factor β1 and angiotensin II, progress in functional genomics, high-throughput sequencing technology, epigenetics and systems biology approaches have greatly expanded our knowledge and uncovered new molecular mechanisms and factors involved in DN. These mechanisms include DNA methylation, chromatin histone modifications, novel transcripts and functional noncoding RNAs, such as microRNAs and long noncoding RNAs. In this Review, we discuss the significance of these emerging mechanisms, how they mediate the actions of growth factors to augment the expression of extracellular matrix and inflammatory genes associated with DN and their potential usefulness as diagnostic biomarkers or novel therapeutic targets for DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
Guttman, M., Amit, I., Garber, M., French, C., Lin, M. F., Feldser, D., Huarte, M., Zuk, O., Carey, B. W., Cassady, J. P., et al. (2009) · Nature · doi:10.1038/nature07672 · Cited by 4,098
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Systematic Localization of Common Disease-Associated Variation in Regulatory DNA
Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716
Cabili, M. N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., & Rinn, J. L. (2011) · Genes & Development · doi:10.1101/gad.17446611 · Cited by 3,502
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
MicroRNA biogenesis: coordinated cropping and dicing
Kim, V. N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1644 · Cited by 2,546
Environmental epigenomics and disease susceptibility
Jirtle, R. L., & Skinner, M. K. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2045 · Cited by 2,492
Long noncoding RNAs: functional surprises from the RNA world
Wilusz, J. E., Sunwoo, H., & Spector, D. L. (2009) · Genes & Development · doi:10.1101/gad.1800909 · Cited by 2,294
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267
Modular regulatory principles of large non-coding RNAs
Guttman, M., & Rinn, J. L. (2012) · Nature · doi:10.1038/nature10887 · Cited by 2,265
ChIP–seq: advantages and challenges of a maturing technology
Park, P. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2641 · Cited by 2,217
Long noncoding RNAs and human disease
Wapinski, O., & Chang, H. Y. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.001 · Cited by 1,900
The NIH Roadmap Epigenomics Mapping Consortium
Bernstein, B. E., Stamatoyannopoulos, J. A., Costello, J. F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Marra, M. A., Beaudet, A. L., Ecker, J. R., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1010-1045 · Cited by 1,892
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Principles and challenges of genome-wide DNA methylation analysis
Laird, P. W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2732 · Cited by 1,572
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Origin and function of myofibroblasts in kidney fibrosis
LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.3218 · Cited by 1,263
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Charting histone modifications and the functional organization of mammalian genomes
Zhou, V. W., Goren, A., & Bernstein, B. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2905 · Cited by 1,147
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115
Podocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
Non‐coding RNAs: regulators of disease
Taft, R. J., Pang, K. C., Mercer, T. R., Dinger, M., & Mattick, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2638 · Cited by 1,058
Gerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Farazi, T. A., Spitzer, J. I., Morozov, P., & Tuschl, T. (2011) · The Journal of Pathology · doi:10.1002/path.2806 · Cited by 895
Regulation of histone methylation by demethylimination and demethylation
Klose, R. J., & Zhang, Y. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2143 · Cited by 887
Receptor-associated Mad homologues synergize as effectors of the TGF-β response
Zhang, Y., Feng, X.-H., Wu, R.-Y., & Derynck, R. (1996) · Nature · doi:10.1038/383168a0 · Cited by 872
Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J. J., & Natarajan, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611192104 · Cited by 699
Self-citationMiR423-5p As a Circulating Biomarker for Heart Failure
Tijsen, A. J., Creemers, E. E., Moerland, P. D., de Windt, L. J., van der Wal, A. C., Kok, W. E., & Pinto, Y. M. (2010) · Circulation Research · doi:10.1161/circresaha.110.218297 · Cited by 664
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Methylation determines fibroblast activation and fibrogenesis in the kidney
Bechtel, W., McGoohan, S., Zeisberg, E. M., Müller, G. A., Kalbacher, H., Salant, D. J., Müller, C. A., Kalluri, R., & Zeisberg, M. (2010) · Nature Medicine · doi:10.1038/nm.2135 · Cited by 639
Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs
Moran, V. A., Perera, R. J., & Khalil, A. M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks296 · Cited by 637
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
Chau, B. N., Xin, C., Hartner, J., Ren, S., Castano, A. P., Linn, G., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 587
Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure
Chen, J.-F., Murchison, E. P., Tang, R., Callis, T. E., Tatsuguchi, M., Deng, Z., Rojas, M., Hammond, S. M., Schneider, M. D., Selzman, C. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710228105 · Cited by 576
TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1897 · Cited by 573
Self-citationIntensive diabetes therapy and glomerular filtration rate in type 1 diabetes
The DCCT/EDIC Research Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1111732 · Cited by 568
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Sharma, K., & Ziyadeh, F. N. (1995) · Diabetes · doi:10.2337/diab.44.10.1139 · Cited by 554
Targeting long non-coding RNA to therapeutically upregulate gene expression
Wahlestedt, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4018 · Cited by 532
Martin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2114 · Cited by 499
Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis
Wang, B., Komers, R., Carew, R., Winbanks, C. E., Xu, B., Herman-Edelstein, M., Koh, P., Thomas, M., Jandeleit-Dahm, K., Gregorevic, P., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010055 · Cited by 498
TGF-β: Regulation of extracellular matrix
Roberts, A. B., McCune, B. K., & Sporn, M. B. (1992) · Kidney International · doi:10.1038/ki.1992.81 · Cited by 493
Progression of Incipient Diabetic Retinopathy During Good Glycemic Control
Engerman, R. L., & Kern, T. S. (1987) · Diabetes · doi:10.2337/diab.36.7.808 · Cited by 490
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
Kriz, W., Kaissling, B., & Le Hir, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44595 · Cited by 455
Biomarkers in chronic kidney disease: a review
Fassett, R. G., Venuthurupalli, S. K., Gobe, G. C., Coombes, J. S., Cooper, M. A., & Hoy, W. E. (2011) · Kidney International · doi:10.1038/ki.2011.198 · Cited by 449
An encyclopedia of mouse DNA elements (Mouse ENCODE)
Mouse ENCODE Consortium, Stamatoyannopoulos, J. A., Snyder, M., Hardison, R., Ren, B., Gingeras, T., Gilbert, D. M., Groudine, M., Bender, M., Kaul, R., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-8-418 · Cited by 446
Meyer, T. W., Bennett, P. H., & Nelson, R. G. (1999) · Diabetologia · doi:10.1007/s001250051447 · Cited by 445
Villeneuve, L. M., Reddy, M. A., Lanting, L. L., Wang, M., Meng, L., & Natarajan, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803623105 · Cited by 412
Self-citationWang, Q., Wang, Y., Minto, A. W., Wang, J., Shi, Q., Li, X., & Quigg, R. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-112326 · Cited by 397
Miao, F., Gonzalo, I. G., Lanting, L., & Natarajan, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311786200 · Cited by 374
Self-citationInhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic Nephropathy
Putta, S., Lanting, L., Sun, G., Lawson, G., Kato, M., & Natarajan, R. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050485 · Cited by 368
Self-citationCirculating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Gohda, T., Niewczas, M. A., Ficociello, L. H., Walker, W. H., Skupien, J., Rosetti, F., Cullere, X., Johnson, A. C., Crabtree, G., Smiles, A. M., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060628 · Cited by 356
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
Zhong, X., Chung, A. C. K., Chen, H. Y., Dong, Y., Meng, X. M., Li, R., Yang, W., Hou, F. F., & Lan, H. Y. (2013) · Diabetologia · doi:10.1007/s00125-012-2804-x · Cited by 355
miR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
Chung, A. C. K., Huang, X. R., Meng, X., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020134 · Cited by 354
Li, Y., Reddy, M. A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., Ren, B., & Natarajan, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802800200 · Cited by 353
Self-citationPodocyte-Selective Deletion of Dicer Induces Proteinuria and Glomerulosclerosis
Shi, S., Yu, L., Chiu, C., Sun, Y., Chen, J., Khitrov, G., Merkenschlager, M., Holzman, L. B., Zhang, W., Mundel, P., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030312 · Cited by 349
Toperoff, G., Aran, D., Kark, J. D., Rosenberg, M., Dubnikov, T., Nissan, B., Wainstein, J., Friedlander, Y., Levy-Lahad, E., Glaser, B., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr472 · Cited by 349
Loss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy
Krupa, A., Jenkins, R., Luo, D. D., Lewis, A., Phillips, A., & Fraser, D. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009050530 · Cited by 348
miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression
Wang, B., Koh, P., Winbanks, C., Coughlan, M. T., McClelland, A., Watson, A., Jandeleit-Dahm, K., Burns, W. C., Thomas, M. C., Cooper, M. E., et al. (2011) · Diabetes · doi:10.2337/db10-0892 · Cited by 345
Sun, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh186 · Cited by 344
Simon, J. M., Giresi, P. G., Davis, I. J., & Lieb, J. D. (2012) · Nature Protocols · doi:10.1038/nprot.2011.444 · Cited by 329
Qian, Y., Feldman, E., Pennathur, S., Kretzler, M., & Brosius, F. C. (2008) · Diabetes · doi:10.2337/db08-0061 · Cited by 325
Podocyte-Specific Deletion of Dicer Alters Cytoskeletal Dynamics and Causes Glomerular Disease
Harvey, S. J., Jarad, G., Cunningham, J., Goldberg, S., Schermer, B., Harfe, B. D., McManus, M. T., Benzing, T., & Miner, J. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020233 · Cited by 320
The RAAS in the pathogenesis and treatment of diabetic nephropathy
Ruggenenti, P., Cravedi, P., & Remuzzi, G. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.58 · Cited by 319
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
Barutta, F., Tricarico, M., Corbelli, A., Annaratone, L., Pinach, S., Grimaldi, S., Bruno, G., Cimino, D., Taverna, D., Deregibus, M. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073798 · Cited by 317
Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., et al. (2009) · Diabetes · doi:10.2337/db08-1328 · Cited by 317
Pop-Busui, R., Low, P. A., Waberski, B. H., Martin, C. L., Albers, J. W., Feldman, E. L., Sommer, C., Cleary, P. A., Lachin, J. M., & Herman, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.837369 · Cited by 310
Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
Bell, C. G., Teschendorff, A. E., Rakyan, V. K., Maxwell, A. P., Beck, S., & Savage, D. A. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-33 · Cited by 305
Discovering the first microRNA-targeted drug
Lindow, M., & Kauppinen, S. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208082 · Cited by 302
Podocyte-Specific Loss of Functional MicroRNAs Leads to Rapid Glomerular and Tubular Injury
Ho, J., Ng, K. H., Rosen, S., Dostal, A., Gregory, R. I., & Kreidberg, J. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020162 · Cited by 297
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
Sandholm, N., Salem, R. M., McKnight, A. J., Brennan, E. P., Forsblom, C., Isakova, T., McKay, G. J., Williams, W. W., Sadlier, D. M., Mäkinen, V.-P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002921 · Cited by 278
Huang, K., Huang, J., Xie, X., Wang, S., Chen, C., Shen, X., Liu, P., & Huang, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.029 · Cited by 269
Novel Long Noncoding RNAs Are Regulated by Angiotensin II in Vascular Smooth Muscle Cells
Leung, A., Trac, C., Jin, W., Lanting, L., Akbany, A., Sætrom, P., Schones, D. E., & Natarajan, R. (2013) · Circulation Research · doi:10.1161/circresaha.112.300849 · Cited by 268
Self-citationLong, J., Wang, Y., Wang, W., Chang, B. H. J., & Danesh, F. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.136168 · Cited by 267
Long, J., Wang, Y., Wang, W., Chang, B. H. J., & Danesh, F. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194969 · Cited by 266
ENCODE whole-genome data in the UCSC Genome Browser: update 2012
Rosenbloom, K. R., Dreszer, T. R., Long, J. C., Malladi, V. S., Sloan, C. A., Raney, B. J., Cline, M. S., Karolchik, D., Barber, G. P., Clawson, H., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1012 · Cited by 257
Chen, S., Jim, B., & Ziyadeh, F. N. (2003) · Seminars in Nephrology · doi:10.1053/s0270-9295(03)00132-3 · Cited by 256
Bell, C. G., Finer, S., Lindgren, C. M., Wilson, G. A., Rakyan, V. K., Teschendorff, A. E., Akan, P., Stupka, E., Down, T. A., Prokopenko, I., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014040 · Cited by 256
de Boer, I. H., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2113 · Cited by 254
Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
Miao, F., Chen, Z., Genuth, S., Paterson, A., Zhang, L., Wu, X., Li, S. M., Cleary, P., Riggs, A., Harlan, D. M., et al. (2014) · Diabetes · doi:10.2337/db13-1251 · Cited by 253
Self-citationWang, Y., & Harris, D. C. H. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030269 · Cited by 247
Miao, F., Smith, D. D., Zhang, L., Min, A., Feng, W., & Natarajan, R. (2008) · Diabetes · doi:10.2337/db08-0645 · Cited by 247
Self-citationWang, B., Herman-Edelstein, M., Koh, P., Burns, W., Jandeleit-Dahm, K., Watson, A., Saleem, M., Goodall, G. J., Twigg, S. M., Cooper, M. E., et al. (2010) · Diabetes · doi:10.2337/db09-1736 · Cited by 244
Kato, M., Arce, L., Wang, M., Putta, S., Lanting, L., & Natarajan, R. (2011) · Kidney International · doi:10.1038/ki.2011.43 · Cited by 238
Self-citationEpigenetic Histone Methylation Modulates Fibrotic Gene Expression
Sun, G., Reddy, M. A., Yuan, H., Lanting, L., Kato, M., & Natarajan, R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060633 · Cited by 238
Self-citationPoncelet, A.-C., & Schnaper, H. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006442200 · Cited by 227
Dey, N., Das, F., Mariappan, M. M., Mandal, C. C., Ghosh-Choudhury, N., Kasinath, B. S., & Choudhury, G. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208066 · Cited by 226
Ko, Y.-A., Mohtat, D., Suzuki, M., Park, A. S. D., Izquierdo, M. C., Han, S. Y., Kang, H. M., Si, H., Hostetter, T., Pullman, J. M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r108 · Cited by 225
Tian, Z., Greene, A. S., Pietrusz, J. L., Matus, I. R., & Liang, M. (2008) · Genome Research · doi:10.1101/gr.6587008 · Cited by 223
Pirola, L., Balcerczyk, A., Tothill, R. W., Haviv, I., Kaspi, A., Lunke, S., Ziemann, M., Karagiannis, T., Tonna, S., Kowalczyk, A., et al. (2011) · Genome Research · doi:10.1101/gr.116095.110 · Cited by 223
Jones, C. A., Krolewski, A. S., Rogus, J., Xue, J. L., Collins, A., & Warram, J. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00265.x · Cited by 218
Lindvall, C., & Lask, B. (2011) · Eating Disorders and the Brain · doi:10.1002/9781119998402.ch10 · Cited by 218
Circulating microRNA expression is reduced in chronic kidney disease
Neal, C. S., Michael, M. Z., Pimlott, L. K., Yong, T. Y., Li, J. Y. Z., & Gleadle, J. M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr485 · Cited by 215
Epigenetics: Mechanisms and Implications for Diabetic Complications
Cooper, M. E., & El-Osta, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.223552 · Cited by 213
Sapienza, C., Lee, J., Powell, J., Erinle, O., Yafai, F., Reichert, J., Siraj, E. S., & Madaio, M. (2011) · Epigenetics · doi:10.4161/epi.6.1.13362 · Cited by 208
MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
Chen, H.-Y., Zhong, X., Huang, X. R., Meng, X.-M., You, Y., Chung, A. C., & Lan, H. Y. (2014) · Molecular Therapy · doi:10.1038/mt.2013.235 · Cited by 199
miR-146a–Mediated Extracellular Matrix Protein Production in Chronic Diabetes Complications
Feng, B., Chen, S., McArthur, K., Wu, Y., Sen, S., Ding, Q., Feldman, R. D., & Chakrabarti, S. (2011) · Diabetes · doi:10.2337/db11-0478 · Cited by 196
Villeneuve, L. M., Kato, M., Reddy, M. A., Wang, M., Lanting, L., & Natarajan, R. (2010) · Diabetes · doi:10.2337/db10-0208 · Cited by 186
Self-citationWang, X. X., Jiang, T., Shen, Y., Caldas, Y., Miyazaki-Anzai, S., Santamaria, H., Urbanek, C., Solis, N., Scherzer, P., Lewis, L., et al. (2010) · Diabetes · doi:10.2337/db10-0019 · Cited by 186
TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression
Hayashida, T., Poncelet, A.-C., Hubchak, S. C., & Schnaper, H. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00733.x · Cited by 185
Downregulation of MicroRNA-30 Facilitates Podocyte Injury and Is Prevented by Glucocorticoids
Wu, J., Zheng, C., Fan, Y., Zeng, C., Chen, Z., Qin, W., Zhang, C., Zhang, W., Wang, X., Zhu, X., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012111101 · Cited by 185
Histone Deacetylase Inhibitor Enhances Recovery after AKI
Cianciolo Cosentino, C., Skrypnyk, N. I., Brilli, L. L., Chiba, T., Novitskaya, T., Woods, C., West, J., Korotchenko, V. N., McDermott, L., Day, B. W., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012111055 · Cited by 184
Colagiuri, S., Cull, C. A., Holman, R. R., & For the UKPDS Group (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1410 · Cited by 183
Miao, F., Wu, X., Zhang, L., Yuan, Y.-C., Riggs, A. D., & Natarajan, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609446200 · Cited by 182
Self-citationYun, J.-M., Jialal, I., & Devaraj, S. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.03.014 · Cited by 182
The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24
Huppi, K., Volfovsky, N., Runfola, T., Jones, T. L., Mackiewicz, M., Martin, S. E., Mushinski, J. F., Stephens, R., & Caplen, N. J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0105 · Cited by 180
Wang, B., Jha, J. C., Hagiwara, S., McClelland, A. D., Jandeleit-Dahm, K., Thomas, M. C., Cooper, M. E., & Kantharidis, P. (2014) · Kidney International · doi:10.1038/ki.2013.372 · Cited by 175
Kato, M., Yuan, H., Xu, Z.-G., Lanting, L., Li, S.-L., Wang, M., Hu, M. C.-T., Reddy, M. A., & Natarajan, R. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070754 · Cited by 175
Self-citationHigh glucose down‐regulates miR‐29a to increase collagen IV production in HK‐2 cells
Du, B., Ma, L.-M., Huang, M.-B., Zhou, H., Huang, H.-L., Shao, P., Chen, Y.-Q., & Qu, L.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.053 · Cited by 168
MicroRNA‐21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice
Zhang, Z., Peng, H., Chen, J., Chen, X., Han, F., Xu, X., He, X., & Yan, N. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.021 · Cited by 168
Kato, M., Wang, L., Putta, S., Wang, M., Yuan, H., Sun, G., Lanting, L., Todorov, I., Rossi, J. J., & Natarajan, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165027 · Cited by 167
Self-citationAlvarez, M. L., & DiStefano, J. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018671 · Cited by 167
Advani, A., Huang, Q., Thai, K., Advani, S. L., White, K., Kelly, D. J., Yuen, D. A., Connelly, K. A., Marsden, P. A., & Gilbert, R. E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.044 · Cited by 167
Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
Argyropoulos, C., Wang, K., McClarty, S., Huang, D. Y. C., Bernardo, J., Ellis, D., Orchard, T. J., Galas, D. J., & Johnson, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054662 · Cited by 166
Dicer regulates the development of nephrogenic and ureteric compartments in the mammalian kidney
Nagalakshmi, V. K., Ren, Q., Pugh, M. M., Valerius, M. T., McMahon, A. P., & Yu, J. (2011) · Kidney International · doi:10.1038/ki.2010.385 · Cited by 166
Sayyed, S. G., Hägele, H., Kulkarni, O. P., Endlich, K., Segerer, S., Eulberg, D., Klussmann, S., & Anders, H.-J. (2009) · Diabetologia · doi:10.1007/s00125-009-1493-6 · Cited by 166
Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy
Kanamori, H., Matsubara, T., Mima, A., Sumi, E., Nagai, K., Takahashi, T., Abe, H., Iehara, N., Fukatsu, A., Okamoto, H., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.148 · Cited by 166
Mahimainathan, L., Das, F., Venkatesan, B., & Choudhury, G. G. (2006) · Diabetes · doi:10.2337/db05-1326 · Cited by 166
The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway
Li, R., Chung, A. C. K., Dong, Y., Yang, W., Zhong, X., & Lan, H. Y. (2013) · Kidney International · doi:10.1038/ki.2013.272 · Cited by 164
Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms
Tonna, S. J., El‐Osta, A., Cooper, M. E., & Tikellis, C. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.55 · Cited by 163
Alvarez, M. L., Khosroheidari, M., Eddy, E., & Kiefer, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077468 · Cited by 162
Deshpande, S. D., Putta, S., Wang, M., Lai, J. Y., Bitzer, M., Nelson, R. G., Lanting, L. L., Kato, M., & Natarajan, R. (2013) · Diabetes · doi:10.2337/db13-0305 · Cited by 161
Self-citationFu, Y., Zhang, Y., Wang, Z., Wang, L., Wei, X., Zhang, B., Wen, Z., Fang, H., Pang, Q., & Yi, F. (2010) · American Journal of Nephrology · doi:10.1159/000322105 · Cited by 159
Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGFβR1
Brennan, E. P., Nolan, K. A., Börgeson, E., Gough, O., McEvoy, C. M., Docherty, N. G., Higgins, D. F., Murphy, M., Sadlier, D. M., Shah, S. T. A., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012060550 · Cited by 159
Role of Nox4 in murine models of kidney disease
Bábelová, A., Avaniadi, D., Jung, O., Fork, C., Beckmann, J., Kosowski, J., Weißmann, N., Anilkumar, N. P., Shah, A. M., Schaefer, L., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.027 · Cited by 152
Yuan, H., Reddy, M. A., Sun, G., Lanting, L. L., Wang, M., Kato, M. V., & Natarajan, R. D. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00523.2012 · Cited by 150
Self-citationZhou, Q., Chung, A. C. K., Huang, X. R., Dong, Y., Yu, X., & Lan, H. Y. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.007 · Cited by 148
Effect of miR-21 on Renal Fibrosis by Regulating MMP-9 and TIMP1 in kk-ay Diabetic Nephropathy Mice
Wang, J., Gao, Y., Ma, M.-F., Li, M., Zou, D., Yang, J., Zhu, Z., & Zhao, X. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9539-2 · Cited by 144
Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice
Reddy, M. A., Putta, S., Lanting, L. L., Yuan, H., Wang, M., Mar, D., Alpers, C. E., Bomsztyk, K., & Natarajan, R. D. (2013) · Kidney International · doi:10.1038/ki.2013.387 · Cited by 134
Self-citationEpigenetics: deciphering its role in diabetes and its chronic complications
Villeneuve, L. M., Reddy, M. A., & Natarajan, R. D. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05497.x · Cited by 131
Self-citationMicroRNAs: Potential Mediators and Biomarkers of Diabetic Complications
Kato, M., Castro, N. E., & Natarajan, R. (2013) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2013.06.009 · Cited by 130
Self-citationKato, M. V., Dang, V., Wang, M., Park, J. T., Deshpande, S., Kadam, S., Mardiros, A., Zhan, Y., Oettgen, P., Putta, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003389 · Cited by 130
Self-citationStimulation of pro-α1(I) collagen by TGF-β1in mesangial cells: role of the p38 MAPK pathway
Chin, B. Y., Mohsenin, A., Li, S. X., Choi, A. M. K., & Choi, M. E. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.3.f495 · Cited by 130
Ichii, O., Otsuka, S., Sasaki, N., Namiki, Y., Hashimoto, Y., & Kon, Y. (2011) · Kidney International · doi:10.1038/ki.2011.345 · Cited by 127
Low‐dose paclitaxel ameliorates fibrosis in the remnant kidney model by down‐regulating miR‐192
Sun, L., Zhang, D., Liu, F., Xiang, X., Ling, G., Xiao, L., Liu, Y., Zhu, X., Zhan, M., Yang, Y., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2961 · Cited by 124
Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies
Sedeek, M. H., Montezano, A. C. I., Hébert, R., Gray, S. P., Marco, E. D., Jha, J. C., Cooper, M. E., Jandeleit-Dahm, K. A. M., Schiffrin, E. L., Wilkinson‐Berka, J. L., et al. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9387-2 · Cited by 121
Micro-RNA Expression in the Urinary Sediment of Patients with Chronic Kidney Diseases
Szeto, C., Ching-Ha, K. B., Lai, K., Lai, F. M., Choi, P. C., Gang, W., Chow, K., & Li, P. K. (2012) · Disease Markers · doi:10.1155/2012/842764 · Cited by 119
Zhdanova, O. A., Srivastava, S., Di, L., Li, Z., Tchelebi, L. T., Dworkin, S., Johnstone, D. B., Zavadil, J., Chong, M. M. W., Littman, D. R., et al. (2011) · Kidney International · doi:10.1038/ki.2011.122 · Cited by 117
New pharmacological treatments for improving renal outcomes in diabetes
Declèves, A., & Sharma, K. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.57 · Cited by 116
Muratsu-Ikeda, S., Nangaku, M., Ikeda, Y., Tanaka, T., Wada, T., & Inagi, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041462 · Cited by 115
Li, S., Reddy, M. A., Cai, Q., Meng, L., Yuan, H., Lanting, L. L., & Natarajan, R. D. (2006) · Diabetes · doi:10.2337/db06-0164 · Cited by 115
Self-citationProfiles of Epigenetic Histone Post-translational Modifications at Type 1 Diabetes Susceptible Genes
Miao, F., Chen, Z., Zhang, L., Liu, Z., Wu, X., Yuan, Y., & Natarajan, R. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330373 · Cited by 114
Self-citationZhang, Z., Luo, X., Ding, S., Chen, J., Chen, T., Chen, X., Zha, H., Li, Y., He, X.-Y., & Peng, H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.042 · Cited by 109
Epigenetics and maternal nutrition: nature v. nurture
Simmons, R. A. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110003988 · Cited by 109
Role of Smad4 on TGF-β–induced extracellular matrix stimulation in mesangial cells
Tsuchida, K., Zhu, Y., Siva, S., Dunn, S., & Sharma, K. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00009.x · Cited by 104
MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice
Pan, Y., Jia, Zhang, Zhang, Zhang, Li, & Wang, L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s37990 · Cited by 103
Role of Platelet-Derived Growth Factor in Renal Injury
Abboud, H. E. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.001501 · Cited by 102
The Pro-Apoptotic Protein Bim Is a MicroRNA Target in Kidney Progenitors
Ho, J., Pandey, P., Schatton, T., Sims‐Lucas, S., Khalid, M., Frank, M. H., Hartwig, S., & Kreidberg, J. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080841 · Cited by 101
Wei, J., Zhang, Y., Luo, Y., Wang, Z., Bi, S., Song, D., Dai, Y., Wang, T., Qiu, L., Wen, L., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.811 · Cited by 100
Epigenetic Modifications in the Pathogenesis of Diabetic Nephropathy
Reddy, M. A., Park, J. T., & Natarajan, R. D. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.05.006 · Cited by 100
Self-citationReversal of hyperglycemia and diabetic nephropathy
Kowluru, R. A., Abbas, S. N., & Odenbach, S. (2004) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.03.002 · Cited by 98
miRNAs as molecular biomarkers of cancer
Fabbri, M. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.27 · Cited by 94
Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for Treatment
Zhu, Y., Usui, H. K., & Sharma, K. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.008 · Cited by 85
Park, J. T., Kato, M. V., Yuan, H., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.453043 · Cited by 83
Self-citationMu, J., Pang, Q., Guo, Y., Chen, J., Zeng, W., Huang, Y., Zhang, J., & Feng, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058622 · Cited by 80
Lü, Q., Zhai, Y., Cheng, Q., Liu, Y., Gao, X., Zhang, T., Wei, Y., Zhang, F., & Yin, X. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.068361 · Cited by 71
Role of Upstream Stimulatory Factors in Regulation of Renal Transforming Growth Factor-β1
Zhu, Y., Casado, M., Vaulont, S., & Sharma, K. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1976 · Cited by 70
Fujita, T., Ogihara, N., Kamura, Y., Satomura, A., Fuke, Y., Shimizu, C., Wada, Y., & Matsumoto, K. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0178-4 · Cited by 66
Yang, Y., Xiao, L., Li, J., Kanwar, Y. S., Liu, F., & Sun, L. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.04.031 · Cited by 61
Towards understanding the inherited susceptibility for nephropathy in diabetes
Thomas, M. C., Groop, P., & Tryggvason, K. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328350313e · Cited by 59
MicroRNA-22 Is a Master Regulator of Bone Morphogenetic Protein-7/6 Homeostasis in the Kidney
Long, J., Badal, S. S., Wang, Y., Chang, B. H., Rodriguez, A., & Danesh, F. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.498634 · Cited by 58
New targets for treatment of diabetic nephropathy: what we have learned from animal models
Brosius, F. C., & Alpers, C. E. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835b3766 · Cited by 56
Urinary sediment miRNA levels in adult nephrotic syndrome
Wang, G., Kwan, B. C., Lai, F. M., Chow, K., Li, P. K., & Szeto, C. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.12.011 · Cited by 56
Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys
Kikuchi, Y., Ikee, R., Hemmi, N., Hyodo, N., Saigusa, T., Namikoshi, T., Yamada, M., Suzuki, S., & Miura, S. (2004) · Nephron Experimental Nephrology · doi:10.1159/000077594 · Cited by 56
Song, K., Park, J., Park, J. H., Natarajan, R. D., & Ha, H. (2013) · Diabetologia · doi:10.1007/s00125-013-2907-z · Cited by 54
Self-citationmiR-192 Induces G2/M Growth Arrest in Aristolochic Acid Nephropathy
Jenkins, R. L., Davies, L. C., Taylor, P. R., Akiyama, H., Cumbes, B., Beltrami, C., Carrington, C., Phillips, A. O., Bowen, T., & Fraser, D. J. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.12.028 · Cited by 53
MicroRNA Circuits in Transforming Growth Factor-β actions and Diabetic Nephropathy
Kato, M., & Natarajan, R. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.04.004 · Cited by 50
Self-citationEpigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes
Komers, R., Mar, D., Denisenko, O. N., Xu, B., Oyama, T., & Bomsztyk, K. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.47 · Cited by 50
Buschur, E., Sarma, A. V., Pietropaolo, M., Dunn, R. L., Braffett, B. H., Cleary, P. A., Cowie, C. C., Larkin, M. E., Wessells, H., Nathan, D. M., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1890 · Cited by 48
Perspectives on Systems Biology Applications in Diabetic Kidney Disease
Komorowsky, C. V., Brosius, F. C., Pennathur, S., & Kretzler, M. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9382-7 · Cited by 40
Ren, S., & Duffield, J. S. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328362485e · Cited by 39
Enhancers: Multi-dimensional signal integrators
Jin, F., Li, Y., Ren, B., & Natarajan, R. D. (2011) · Transcription · doi:10.4161/trns.2.5.17712 · Cited by 38
Self-citationEmerging Roles for miRNAs in the Development, Diagnosis, and Treatment of Diabetic Nephropathy
DiStefano, J. K., Taila, M., & Alvarez, M. L. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0386-8 · Cited by 29
Grossniklaus, H. E. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01717-8 · Cited by 27
Stower, H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3341 · Cited by 11
Oxidative and Endoplasmic Reticulum (ER) Stress in Tissue Fibrosis
Inagi, R., Shoji, K., & Nangaku, M. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0029-4 · Cited by 6
Cited by
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease
Huang, G., Li, M., Li, Y., & Mao, Y. (2022) · Laboratory Medicine · doi:10.1093/labmed/lmac041 · Cited by 922
Renal tubule injury: a driving force toward chronic kidney disease
Liu, B.-C., Tang, T.-T., Lv, L.-L., & Lan, H.-Y. (2018) · Kidney International · doi:10.1016/j.kint.2017.09.033 · Cited by 913
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Self-citationEpigenetic mechanisms in diabetic complications and metabolic memory
Reddy, M. A., Zhang, E., & Natarajan, R. (2015) · Diabetologia · doi:10.1007/s00125-014-3462-y · Cited by 496
Self-citation
Metadata
- Authors
- Kato, M., & Natarajan, R.
- Venue
- Nature Reviews Nephrology
- Published
- 2014-07-08
- Volume
- 10
- Issue
- 9
- Pages
- 517-530
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W1492748176
- Cited by
- 318
- References
- 195
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.